Background and ObjectiveMany countries require hospitals to implement medication reconciliation for accreditation, but the process is resource-intensive, thus adherence is poor. We report on the impact of prepopulating and aligning community and hospital drug lists with data from population-based and hospital-based drug information systems to reduce workload and enhance adoption and use of an e-medication reconciliation application, RightRx.MethodsThe prototype e-medical reconciliation web-based software was developed for a cluster-randomized trial at the McGill University Health Centre. User-centered design and agile development processes were used to develop features intended to enhance adoption, safety, and efficiency. RightRx was implemented in medical and surgical wards, with support and training provided by unit champions and field staff. The time spent per professional using RightRx was measured, as well as the medication reconciliation completion rates in the intervention and control units during the first 20 months of the trial.ResultsUsers identified required modifications to the application, including the need for dose-based prescribing, the role of the discharge physician in prescribing community-based medication, and access to the rationale for medication decisions made during hospitalization. In the intervention units, both physicians and pharmacists were involved in discharge reconciliation, for 96.1% and 71.9% of patients, respectively. Medication reconciliation was completed for 80.7% (surgery) to 96.0% (medicine) of patients in the intervention units, and 0.7% (surgery) to 82.7% of patients in the control units. The odds of completing medication reconciliation were 9 times greater in the intervention compared to control units (odds ratio: 9.0, 95% confidence interval, 7.4-10.9, P < .0001) after adjusting for differences in patient characteristics.ConclusionHigh rates of medication reconciliation completion were achieved with automated prepopulation and alignment of community and hospital medication lists.
Early adopters were mostly in primary care settings, and were accessing it more frequently when using a certified electronic medical record. Further work is needed to investigate how to resolve accuracy issues with the medication list and how certain tools provide different features.
The striped cucumber beetle (SCB) Acalymma vittatum (F.) (Coleptera: Chrysomelidae) is a prime problem in North American cucurbit crops. While certain chemical pesticides efficiently control SCB in conventional cucurbit fields, alternative solutions are required due to the ever-evolving regulations on pesticides. For organic producers, very few control methods exist. A novel mass trapping method demonstrates the potential of controlling SCBs using floral-based semiochemical baited traps in cucurbit crops. The goals of this study were to (1) determine whether baited traps capture more SCBs than unbaited ones, and (2) optimize the trapping method by comparing different trap types and different commercially available attractants to maximize SCB captures while minimizing non-target species captures. The results of a first experiment showed that baited traps captured significantly more SCBs than unbaited ones. Baited traps also captured significantly more bees and hoverflies than unbaited ones. In a second experiment these unwanted captures were drastically reduced by using traps with ten 4 mm in diameter holes per side. Finally, a third experiment demonstrated that the attractant 40CT313 was the most efficient at capturing SCB compared to other tested lures. Overall, the optimized mass trapping technique demonstrated a potential to effectively control SCB populations in organic cucurbit crops.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.